GL1X · GenesisL1 explorer

Research workbench

Identification of a novel allosteric binding site for rorgt inhibitors

Analyse Identification of a novel allosteric binding site for rorgt inhibitors in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5C4S
Type
protein
Length
241 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Nuclear receptor ror-gamma
UniProt
P51449
Ligands
4Y5
Pockets
5 · best druggability 0.82

Structure

x-ray diffraction · 1 distinct chain · 70% helix, 4% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANuclear receptor ror-gammaprotein24170% helix, 4% strandP51449

Ligands and binding sites

  • 4Y5 · 4-{1-[2-chloro-6-(trifluoromethyl)benzoyl]-4-fluoro-1H-indazol-3-yl}-3-fluorobenzoic acid · ligand · chains A
  • GOL · Glycerol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14000.820.9038GOL
22020.800.93284Y5
31810.540.7920empty
4720.400.7915empty
5870.330.7417empty

Compared structures

  • 5C4S · Identification of a Novel Allosteric Binding Site for RORgt Inhibitors · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.